Amedeo Smart

Free Medical Literature Service



Colorectal Neoplasms

  Free Subscription


1 Ann Surg
1 Ann Surg Oncol
4 BMC Cancer
1 Br J Cancer
1 Cancer
1 Dis Colon Rectum
1 Gut
1 Int J Cancer
1 Int J Oncol
3 J Clin Oncol
1 J Surg Oncol
2 Lancet Oncol
2 Oncol Rep
1 World J Surg

    Ann Surg

  1. VALLANCE AE, Keller DS, Hill J, Braun M, et al
    Role of Emergency Laparoscopic Colectomy for Colorectal Cancer: A Population-Based Study in England.
    Ann Surg. 2018 Apr 4. doi: 10.1097/SLA.0000000000002752.
    >> Share

    Ann Surg Oncol

    AJCC 8th Edition: Colorectal Cancer.
    Ann Surg Oncol. 2018 Apr 3. pii: 10.1245/s10434-018-6462.
    >> Share

    BMC Cancer

  3. SHEN MH, Chen LP, Ho TF, Shih YY, et al
    Validation of the Taiwan Chinese version of the EORTC QLQ-CR29 to assess quality of life in colorectal cancer patients.
    BMC Cancer. 2018;18:353.
    >> Share

  4. SHIBUTANI M, Maeda K, Nagahara H, Fukuoka T, et al
    A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study.
    BMC Cancer. 2018;18:371.
    >> Share

  5. WANG H, Chen X, Liu H, Mou T, et al
    Laparoscopy-assisted colectomy as an Oncologically safe alternative for patients with stage T4 Colon Cancer: a propensity-matched cohort study.
    BMC Cancer. 2018;18:370.
    >> Share

  6. SHIN HY, Suh M, Choi KS, Hwang SH, et al
    Higher satisfaction with an alternative collection device for stool sampling in colorectal cancer screening with fecal immunochemical test: a cross-sectional study.
    BMC Cancer. 2018;18:365.
    >> Share

    Br J Cancer

  7. BERGHEIM J, Semaan A, Gevensleben H, Groening S, et al
    Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study.
    Br J Cancer. 2018 Apr 3. pii: 10.1038/s41416-018-0035.
    >> Share


  8. MOLS F, Schoormans D, de Hingh I, Oerlemans S, et al
    Symptoms of anxiety and depression among colorectal cancer survivors from the population-based, longitudinal PROFILES Registry: Prevalence, predictors, and impact on quality of life.
    Cancer. 2018 Apr 6. doi: 10.1002/cncr.31369.
    >> Share

    Dis Colon Rectum

  9. PULTE D, Jansen L, Brenner H
    Disparities in Colon Cancer Survival by Insurance Type: A Population-Based Analysis.
    Dis Colon Rectum. 2018;61:538-546.
    >> Share


  10. SMITH T, Muller DC, Moons KGM, Cross AJ, et al
    Comparison of prognostic models to predict the occurrence of colorectal cancer in asymptomatic individuals: a systematic literature review and external validation in the EPIC and UK Biobank prospective cohort studies.
    Gut. 2018 Apr 3. pii: gutjnl-2017-315730. doi: 10.1136/gutjnl-2017-315730.
    >> Share

    Int J Cancer

  11. LIU X, Zhou W, Zhang X, Ding Y, et al
    1-L-MT, an IDO inhibitor, prevented colitis-associated cancer by inducing CDC20 inhibition-mediated mitotic death of colon cancer cells.
    Int J Cancer. 2018 Apr 1. doi: 10.1002/ijc.31417.
    >> Share

    Int J Oncol

  12. WU S, Wu F, Jiang Z
    Effect of HOXA6 on the proliferation, apoptosis, migration and invasion of colorectal cancer cells.
    Int J Oncol. 2018 Apr 2. doi: 10.3892/ijo.2018.4352.
    >> Share

    J Clin Oncol

  13. SOBRERO A, Lonardi S, Rosati G, Di Bartolomeo M, et al
    FOLFOX or CAPOX in Stage II to III Colon Cancer: Efficacy Results of the Italian Three or Six Colon Adjuvant Trial.
    J Clin Oncol. 2018 Apr 5:JCO2017762187. doi: 10.1200/JCO.2017.76.2187.
    >> Share

  14. ANDRE T, Vernerey D, Mineur L, Bennouna J, et al
    3 Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial.
    J Clin Oncol. 2018 Apr 5:JCO2017760355. doi: 10.1200/JCO.2017.76.0355.
    >> Share

    Advances in Adjuvant Therapy for Colon Cancer: P value or Practical Value.
    J Clin Oncol. 2018 Apr 5:JCO2018778423. doi: 10.1200/JCO.2018.77.8423.
    >> Share

    J Surg Oncol

  16. MARQUES MC, C Ribeiro HS, Costa WL Jr., de Jesus VHF, et al
    Is primary sidedness a prognostic factor in patients with resected colon cancer liver metastases (CLM)?
    J Surg Oncol. 2018 Apr 2. doi: 10.1002/jso.25048.
    >> Share

    Lancet Oncol

  17. ILSON DH
    Adjuvant therapy in colon cancer: less is more.
    Lancet Oncol. 2018;19:442-443.
    >> Share

  18. IVESON TJ, Kerr RS, Saunders MP, Cassidy J, et al
    3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial.
    Lancet Oncol. 2018;19:562-578.
    >> Share

    Oncol Rep

  19. REN W, Wang T, He X, Zhang Q, et al
    betaarrestin2 promotes 5FUinduced apoptosis via the NFkappaB pathway in colorectal cancer.
    Oncol Rep. 2018 Mar 30. doi: 10.3892/or.2018.6340.
    >> Share

  20. LIU W, Li L, Ye H, Tao H, et al
    Role of COL6A3 in colorectal cancer.
    Oncol Rep. 2018 Mar 23. doi: 10.3892/or.2018.6331.
    >> Share

    World J Surg

  21. MATSUDA T, Sumi Y, Yamashita K, Hasegawa H, et al
    Optimal Surgery for Mid-Transverse Colon Cancer: Laparoscopic Extended Right Hemicolectomy Versus Laparoscopic Transverse Colectomy.
    World J Surg. 2018 Apr 2. pii: 10.1007/s00268-018-4612.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016